Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar Epithelium

ACS Nano

Volumn 8, Issue 11, 2014, Pages 11778-11789

  Thorley, Andrew J ^a   Ruenraroengsak, Pakatip ^a,b   Potter, Thomas E ^a   Tetley, Teresa D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Endocytosis; Epithelial; Human; Lung; Nanoparticles; siRNA; Surfactant

Indexed keywords

BIOLOGICAL ORGANS; CONTROLLED DRUG DELIVERY; CYTOLOGY; MOLECULAR BIOLOGY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; SURFACE ACTIVE AGENTS; TARGETED DRUG DELIVERY;

ENDOCYTOSIS; EPITHELIAL; HUMAN; LUNG; SIRNA;

CELLS;

NANOPARTICLE;

HUMAN; LUNG ALVEOLUS; METABOLISM; TRANSFORMED CELL LINE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL LINE, TRANSFORMED; HUMANS; NANOPARTICLES; PULMONARY ALVEOLI;

EID: 84912571932     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn505399e     Document Type: Article

References (56)

1. The Project on Emerging Nanotechnologies: Consumer Product Inventory. The Woodrow Wilson International Center for Scholars. 2014. http://www.nanotechproject.org/cpi (accessed Oct 26, 2014).
2. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers As an Emerging Platform for Cancer Therapy. Nat. Nano. 2007, 2, 751-760.
3. Davis, M. E.; Zuckerman, J. E.; Choi, C. H.; Seligson, D.; Tolcher, A.; Alabi, C. A.; Yen, Y.; Heidel, J. D.; Ribas, A. Evidence of RNAi in Humans from Systemically Administered siRNA Via Targeted Nanoparticles. Nature 2010, 464, 1067-1070.
4. Kurmi, B. D.; Kayat, J.; Gajbhiye, V.; Tekade, R. K.; Jain, N. K. Micro- and Nanocarrier-mediated Lung Targeting. Expert. Opin. Drug Delivery 2010, 7, 781-794.
5. Thorley, A. J.; Tetley, T. D. New Perspectives in Nanomedicine. Pharmacol. Ther. 2013, 140, 176-185.
6. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles. Environ. Health Perspect. 2005, 113, 823-839.
7. Wang, S.; Singh, R. D.; Godin, L.; Pagano, R. E.; Hubmayr, R. D. Endocytic Response of Type I Alveolar Epithelial Cells to Hypertonic Stress. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 300, L560-L568.
8. Williams, M. C. Alveolar Type I Cells: Molecular Phenotype and Development. Annu. Rev. Physiol. 2003, 65, 669-695.
9. Kendall, M.; Guntern, J.; Lockyer, N. P.; Jones, F. H.; Hutton, B. M.; Lippman, M.; Tetley, T. D. Urban PM2.5 Surface Chemistry and Interactions with Bronchoalveolar Lavage Fluid. Inhal. Toxicol. 2004, 16, 115-129.
10. Schurch, S.; Gehr, P.; Im Hof, V.; Geiser, M.; Green, F. Surfactant Displaces Particles toward the Epithelium in Airways and Alveoli. Respir. Physiol. 1990, 80, 17-32.
11. Fisher, A. B.; Dodia, C.; Ruckert, P.; Tao, J. Q.; Bates, S. R. Pathway to Lamellar Bodies for Surfactant Protein A. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 299, L51-L58.
12. Griese, M.; Beck, J.; Feuerhake, F. Surfactant Lipid Uptake and Metabolism by Neonatal and Adult Type II Pneumocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 1999, 277, L901-L909.
13. Takenaka, S.; Karg, E.; Kreyling, W. G.; Lentner, B.; Möller, W.; Behnke-Semmler, M.; Jennen, L.; Walch, A.; Michalke, B.; Schramel, P.; et al. Distribution Pattern of Inhaled Ultrafine Gold Particles in the Rat Lung. Inhal. Toxicol. 2006, 18, 733-740.
14. Sung, J. H.; Ji, J. H.; Park, J. D.; Yun, J. U.; Kim, D. S.; Jeon, K. Sf.; Song, M. Y.; Jeong, J.; Han, B. S.; Han, J. H.; et al. Subchronic Inhalation Toxicity of Silver Nanoparticles. Toxicol. Sci. 2008, 108, 452-461.
15. Kemp, S. J.; Thorley, A. J.; Gorelik, J.; Seckl, M. J.; O'Hare, M. J.; Arcaro, A.; Korchev, Y.; Goldstraw, P.; Tetley, T. D. Immortalization of Human Alveolar Epithelial Cells to Investigate Nanoparticle Uptake. Am. J. Respir. Cell Mol. Biol. 2008, 39, 591-597.
16. dos Santos, T.; Varela, J.; Lynch, I.; Salvati, A.; Dawson, K. A. Effects of Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene Nanoparticles in Different Cell Lines. PLoS One 2011, 6, e24438.
17. Vercauteren, D.; Vandenbroucke, R. E.; Jones, A. T.; Rejman, J.; Demeester, J.; De Smedt, S. C.; Sanders, N. N.; Braeckmans, K. The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls. Mol. Ther. 2010, 18, 561-569.
18. Ruenraroengsak, P.; Novak, P.; Berhanu, D.; Thorley, A. J.; Valsami-Jones, E.; Gorelik, J.; Korchev, Y. E.; Tetley, T. D. Respiratory Epithelial Cytotoxicity and Membrane Damage (Holes) Caused by Amine-modified Nanoparticles. Nanotoxicology 2012, 6, 94-108.
19. Grabowski, N.; Hillaireau, H.; Vergnaud, J.; Santiago, L. A.; Kerdine-Romer, S.; Pallardy, M.; Tsapis, N.; Fattal, E. Toxicity of Surface-modified PLGA Nanoparticles toward Lung Alveolar Epithelial Cells. Int. J. Pharm. 2013, 454, 686-694.
20. Varela, J. A.; Bexiga, M. G.; Aberg, C.; Simpson, J. C.; Dawson, K. A. Quantifying Size-Dependent Interactions between Fluorescently Labeled Polystyrene Nanoparticles and Mammalian Cells. J. Nanobiotechnol. 2012, 10, 39.
21. Dorney, J.; Bonnier, F.; Garcia, A.; Casey, A.; Chambers, G.; Byrne, H. J. Identifying and Localizing Intracellular Nanoparticles Using Raman Spectroscopy. Analyst 2012, 137, 1111-1119.
22. Swain, R. J.; Kemp, S. J.; Goldstraw, P.; Tetley, T. D.; Stevens, M. M. Assessment of Cell Line Models of Primary Human Cells by Raman Spectral Phenotyping. Biophys. J. 2010, 98, 1703-1711.
23. Thorley, A. J.; Grandolfo, D.; Lim, E.; Goldstraw, P.; Young, A.; Tetley, T. D. Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung - Role of Alveolar Epithelial TLR Expression and Signalling. PLoS One 2011, 6, e21827.
24. Gao, H.; Shi, W.; Freund, L. B. Mechanics of Receptor-mediated Endocytosis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 9469-9474.
25. Limbach, L. K.; Li, Y.; Grass, R. N.; Brunner, T. J.; Hintermann, M. A.; Muller, M.; Gunther, D.; Stark, W. J. Oxide Nanoparticle Uptake in Human Lung Fibroblasts: Effects of Particle Size, Agglomeration, and Diffusion at Low Concentrations. Environ. Sci. Technol. 2005, 39, 9370-9376.
26. Herzog, F.; Loza, K.; Balog, S.; Clift, M. J.; Epple, M.; Gehr, P.; Petri-Fink, A.; Rothen-Rutishauser, B. Mimicking Exposures to Acute and Lifetime Concentrations of Inhaled Silver Nanoparticles by Two Different In Vitro Approaches. Beilstein J. Nanotechnol. 2014, 5, 1357-1370.
27. Sarlo, K.; Blackburn, K. L.; Clark, E. D.; Grothaus, J.; Chaney, J.; Neu, S.; Flood, J.; Abbott, D.; Bohne, C.; Casey, K.; et al. Tissue Distribution of 20nm, 100nm and 1000nm Fluorescent Polystyrene Latex Nanospheres Following Acute Systemic or Acute and Repeat Airway Exposure in the Rat. Toxicology 2009, 263, 117-126.
28. Schleh, C.; Holzwarth, U.; Hirn, S.; Wenk, A.; Simonelli, F.; Schaffler, M.; Möller, W.; Gibson, N.; Kreyling, W. G. Biodistribution of Inhaled Gold Nanoparticles in Mice and the Influence of Surfactant Protein D. J. Aerosol Med. Pulm. Drug Delivery 2012, 26, 24-30.
29. Naota, M.; Shimada, A.; Morita, T.; Inoue, K.; Takano, H. Translocation Pathway of the Intratracheally Instilled C60 Fullerene from the Lung into the Blood Circulation in the Mouse: Possible Association of Diffusion and Caveolae-mediated Pinocytosis. Toxicol. Pathol. 2009, 37, 456-462.
30. Liu, J.; Gong, T.; Fu, H.; Wang, C.; Wang, X.; Chen, Q.; Zhang, Q.; He, Q.; Zhang, Z. Solid Lipid Nanoparticles for Pulmonary Delivery of Insulin. Int. J. Pharm. 2008, 356, 333-344.
31. Neumiller, J. J.; Campbell, R. K. Technosphere Insulin: An Inhaled Prandial Insulin Product. BioDrugs 2010, 24, 165-172.
32. Xia, T.; Kovochich, M.; Liong, M.; Zink, J. I.; Nel, A. E. Cationic Polystyrene Nanosphere Toxicity Depends on Cell-Specific Endocytic and Mitochondrial Injury Pathways. ACS Nano 2008, 2, 85-96.
33. Lipka, J.; Semmler-Behnke, M.; Sperling, R. A.; Wenk, A.; Takenaka, S.; Schleh, C.; Kissel, T.; Parak, W. J.; Kreyling, W. G. Biodistribution of PEG-Modified Gold Nanoparticles Following Intratracheal Instillation and Intravenous Injection. Biomaterials 2010, 31, 6574-6581.
34. Porter, D. W.; Wu, N.; Hubbs, A. F.; Mercer, R. R.; Funk, K.; Meng, F.; Li, J.; Wolfarth, M. G.; Battelli, L.; Friend, S.; et al. Differential Mouse Pulmonary Dose and Time Course Responses to Titanium Dioxide Nanospheres and Nanobelts. Toxicol. Sci. 2013, 131, 179-193.
35. Kim, K. J.; Malik, A. B. Protein Transport across the Lung Epithelial Barrier. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284, L247-L259.
36. Merkel, O. M.; Rubinstein, I.; Kissel, T. siRNA Delivery to the Lung: What's New? Adv. Drug Delivery Rev. 2014, 75, 112-128.
37. Hastings, R. H.; Wright, J. R.; Albertine, K. H.; Ciriales, R.; Matthay, M. A. Effect of Endocytosis Inhibitors on Alveolar Clearance of Albumin, Immunoglobulin G, and SP-A in Rabbits. Am. J. Physiol. 1994, 266, L544-552.
38. Yacobi, N. R.; Malmstadt, N.; Fazlollahi, F.; DeMaio, L.; Marchelletta, R.; Hamm-Alvarez, S. F.; Borok, Z.; Kim, K. J.; Crandall, E. D. Mechanisms of Alveolar Epithelial Translocation of a Defined Population of Nanoparticles. Am. J. Respir. Cell Mol. Biol. 2010, 42, 604-614.
39. Novak, P.; Shevchuk, A.; Ruenraroengsak, P.; Miragoli, M.; Thorley, A. J.; Klenerman, D.; Lab, M. J.; Tetley, T. D.; Gorelik, J.; Korchev, Y. E. Imaging Single Nanoparticle Interactions with Human Lung Cells Using Fast Ion Conductance Microscopy. Nano Lett. 2014, 14, 1202-1207.
40. Leo, B. F.; Chen, S.; Kyo, Y.; Herpoldt, K. L.; Terrill, N. J.; Dunlop, I. E.; McPhail, D. S.; Shaffer, M. S.; Schwander, S.; Gow, A.; et al. The Stability of Silver Nanoparticles in a Model of Pulmonary Surfactant. Environ. Sci. Technol. 2013, 47, 11232-11240.
41. Gasser, M.; Wick, P.; Clift, M. J.; Blank, F.; Diener, L.; Yan, B.; Gehr, P.; Krug, H. F.; Rothen-Rutishauser, B. Pulmonary Surfactant Coating of Multi-Walled Carbon Nanotubes (MWCNTs) Influences their Oxidative and Pro-Inflammatory Potential In Vitro. Part. Fibre Toxicol. 2012, 9, 17.
42. Ruge, C. A.; Schaefer, U. F.; Herrmann, J.; Kirch, J.; Cañadas, O.; Echaide, M.; Perez-Gil, J.; Casals, C.; Müller, R.; Lehr, C. M. The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles. PLoS One 2012, 7, e40775.
43. Benfer, M.; Kissel, T. Cellular Uptake Mechanism and Knockdown Activity of siRNA-Loaded Biodegradable DEAPA-PVA-g-PLGA Nanoparticles. Eur. J. Pharm. Biopharm. 2012, 80, 247-256.
44. Nguyen, J.; Reul, R.; Betz, T.; Dayyoub, E.; Schmehl, T.; Gessler, T.; Bakowsky, U.; Seeger, W.; Kissel, T. Nanocomposites of Lung Surfactant and Biodegradable Cationic Nanoparticles Improve Transfection Efficiency to Lung Cells. J. Controlled Release 2009, 140, 47-54.
45. Bernhard, W.; Mottaghian, J.; Gebert, A.; Rau, G. A.; von der Hardt, H.; Poets, C. F. Commercial Versus Native Surfactants. Am. J. Respir. Crit. Care Med. 2000, 162, 1524-1533.
46. Schulze, C.; Schaefer, U. F.; Ruge, C. A.; Wohlleben, W.; Lehr, C. M. Interaction of Metal Oxide Nanoparticles with Lung Surfactant Protein A. Eur. J. Pharm. Biopharm. 2011, 77, 376-383.
47. Kendall, M.; Ding, P.; Mackay, R. M.; Deb, R.; McKenzie, Z.; Kendall, K.; Madsen, J.; Clark, H. Surfactant Protein D (SP-D) Alters Cellular Uptake of Particles and Nanoparticles. Nanotoxicology 2012, 7, 963-973.
48. Kishore, U.; Greenhough, T. J.; Waters, P.; Shrive, A. K.; Ghai, R.; Kamran, M. F.; Bernal, A. L.; Reid, K. B. M.; Madan, T.; Chakraborty, T. Surfactant Proteins SP-A and SP-D: Structure, Function and Receptors. Mol. Immunol. 2006, 43, 1293-1315.
49. Sano, H.; Chiba, H.; Iwaki, D.; Sohma, H.; Voelker, D. R.; Kuroki, Y. Surfactant Proteins A and D Bind CD14 by Different Mechanisms. J. Biol. Chem. 2000, 275, 22442-22451.
50. Ohya, M.; Nishitani, C.; Sano, H.; Yamada, C.; Mitsuzawa, H.; Shimizu, T.; Saito, T.; Smith, K.; Crouch, E.; Kuroki, Y. Human Pulmonary Surfactant Protein D Binds the Extracellular Domains of Toll-like Receptors 2 and 4 Through the Carbohydrate Recognition Domain by a Mechanism Different from its Binding to Phosphatidylinositol and Lipopolysaccharide. Biochemistry 2006, 45, 8657-8664.
51. O'Hare, M. J.; Bond, J.; Clarke, C.; Takeuchi, Y.; Atherton, A. J.; Berry, C.; Moody, J.; Silver, A. R. J.; Davies, D. C.; Alsop, A. E.; et al. Conditional Immortalization of Freshly Isolated Human Mammary Fibroblasts and Endothelial Cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 646-651.
52. Witherden, I. R.; Tetley, T. D. Isolation and Culture of Human Alveolar Type II Pneumocytes. In Human Airway Inflammation; Sampling Techniques and Analytical Protocols; Rogers, D. F., Donnelly, L. D., Ed.; Humana Press: Totowa, 2001; pp 137-146.
53. Witherden, I. R.; Vanden Bon, E. J.; Goldstraw, P.; Ratcliffe, C.; Pastorino, U.; Tetley, T. D. Primary Human Alveolar Type II Epithelial Cell Chemokine Release: Effects of Cigarette Smoke and Neutrophil Elastase. Am. J. Respir. Cell Mol. Biol. 2004, 30, 500-509.
54. Vranic, S.; Boggetto, N.; Contremoulins, V.; Mornet, S.; Reinhardt, N.; Marano, F.; Baeza-Squiban, A.; Boland, S. Deciphering the Mechanisms of Cellular Uptake of Engineered Nanoparticles by Accurate Evaluation of Internalization Using Imaging Flow Cytometry. Part. Fibre Toxicol. 2013, 10, 2.
55. Endres, T.; Zheng, M.; Klc¸, A.; Turowska, A.; Beck-Broichsitter, M.; Renz, H.; Merkel, O. M.; Kissel, T. Amphiphilic Biodegradable PEG-PCL-PEI Triblock Copolymers for FRET-Capable In Vitro and In Vivo Delivery of siRNA and Quantum Dots. Mol. Pharmaceutics 2014, 11, 1273-1281.
56. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 14265-14270.